Onconephrology: Core Curriculum 2023.
AKI
CKD
cancer
hypertension
onconephrology
proteinuria
Journal
American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075
Informations de publication
Date de publication:
12 2023
12 2023
Historique:
received:
20
12
2022
revised:
04
04
2023
accepted:
20
04
2023
medline:
24
11
2023
pubmed:
19
10
2023
entrez:
19
10
2023
Statut:
ppublish
Résumé
Onconephrology focuses on management of kidney disease in cancer, which manifests itself in a variety of clinical syndromes, including acute kidney injury, chronic kidney disease, hypertension, proteinuria, and electrolyte disorders. Many of these syndromes result from cancer treatments including chemotherapy, immunotherapy, chimeric antigen receptor T cells, and stem cell transplant. Others are due to kidney-specific effects of the cancer, as seen with monoclonal gammopathy or glomerular diseases associated with malignancy. Further, cancer risk itself is heightened in patients with kidney disease, particularly kidney transplant recipients, and their care requires specific considerations. In this installment of AJKD's Core Curriculum in Nephrology, we review these and other core concepts in onconephrology, using a case-based approach to highlight clinical decision making.
Identifiants
pubmed: 37855786
pii: S0272-6386(23)00739-4
doi: 10.1053/j.ajkd.2023.04.014
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
743-761Informations de copyright
Copyright © 2023 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.